Search - tctmd.com

Displaying 1 - 20 of 384

Sort: Relevancy | Date

Loberamisal Scores a Rare Win for Stroke Neuroprotection

News Conference News ISC 2026

Loberamisal Scores a Rare Win for Stroke Neuroprotection

February 12, 2026

OPTION: IV Tenecteplase Boosts Outcomes Late After Non-LVO Stroke

News Conference News ISC 2026

OPTION: IV Tenecteplase Boosts Outcomes Late After Non-LVO Stroke

February 11, 2026

OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding

News Conference News ISC 2026

OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding

February 09, 2026

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

News Conference News ISC 2026

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

February 06, 2026

TCTMD’s Top 10 Most Popular Stories for January 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2026

February 02, 2026

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

News Daily News

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

January 29, 2026

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

News Daily News

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

Michael O'Riordan

January 09, 2026

Thrombolysis May Be OK for DOAC-Treated Patients With Ischemic Stroke

News Daily News

Thrombolysis May Be OK for DOAC-Treated Patients With Ischemic Stroke

January 07, 2026

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

News Daily News

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

Michael O'Riordan

November 24, 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

October 09, 2025

Evolocumab Wins for Primary Prevention in VESALIUS-CV

News Daily News

Evolocumab Wins for Primary Prevention in VESALIUS-CV

October 03, 2025

Risk Factors Present in Nearly All Patients Who Develop CVD

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

September 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

September 30, 2025

CVD Still the Leading Cause of Death and Disease Globally

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

News Conference News ESC 2025

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

August 29, 2025

HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke

News Daily News

HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke

August 11, 2025

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

No Clear Risk of Dementia After TIA: Framingham Heart Study

News Daily News

No Clear Risk of Dementia After TIA: Framingham Heart Study

July 10, 2025

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.